Skip to content

A STUDY ON THALISATHY CHOORANAM (INTERNAL) AND LAGUVISHAMUTTI THYLAM (EXTERNAL) IN THE MANAGEMENT OF SAGANAVATHAM (CERVICAL SPONDYLOSIS)

AN OPEN CLINICAL TRIAL TO EVALUATE THE EFFECTIVENESS OF â??THALISATHY CHOORANAM (INTERNAL) AND LAGUVISHAMUTTI THYLAM (EXTERNAL) IN THE MANAGEMENT OF SAGANAVATHAM (CERVICAL SPONDYLOSIS) AMONG THE PATIENTS ATTENDING AYOTHIDOSS PANDITHAR HOSPITAL,NATIONAL INSTITUTE OF SIDDHA.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/02/049642
Enrollment
10
Registered
2023-02-13
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M478- Other spondylosis

Interventions

Intervention1: Thalisathy chooranam (internal) Laguvishamutti thylam (extrenal): Internal 2gms bd with milk External oil 10ml application For 48 days Control Intervention1: NIL: NIL

Sponsors

National institute of siddha
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Neck pain radiating to back of head,top of shoulders,shoulder blades,upper arms and hands 2. Neck stiffness and restricted movements of neck. 3. Numbness and paresthesia of neck or shoulders or upper limbs 4. The Neck Disability Index score should be equal or greater than 40% 5. Patient who are willing to sign informed consent form. 6. Patients who are willing to give radiological investigation.

Exclusion criteria

Exclusion criteria: 1. Traumatic injury 2. Ischemic heart diseases 3.Chronic Kidney disease 4. Tuberculosis in spine 5. Congenital spinal anomalies 6. Pregnant women and lactating mothers. 7. Cervical Rib 8. Ankylosing spondylitis 9.Adhesive capsulitis 10.Diabetes mellitus (uncontrolled)

Design outcomes

Primary

MeasureTime frame
The therapeutic efficacy of trial drug is assessed through improvement in neck disability index score and Visual pain analog scale before and after treatmentTimepoint: 2 MONTHS- SCREENING 2 MONTHS- DATA COLLECTION 2 MONTHS- DATA ANALYSIS AND OUTCOME

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr P Dhanakumari

National institute of siddha

drhnalinisofia@gmail.com8939899363

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026